{"count":27,"next":"https://lda.gov/api/v1/filings/?filing_specific_lobbying_issues=S.+3932&filing_year=2026&ordering=-filing_year&page=2","previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/671082a0-5c40-4c78-8006-6531d6f495aa/","filing_uuid":"671082a0-5c40-4c78-8006-6531d6f495aa","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/671082a0-5c40-4c78-8006-6531d6f495aa/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Nathan Parsons-Schwarz","dt_posted":"2026-04-16T09:46:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"PO Box 833","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Annandale","registrant_state":"VA","registrant_zip":"22003","registrant":{"id":400531585,"url":"https://lda.gov/api/v1/registrants/400531585/","house_registrant_id":null,"name":"ALLEGIANCE STRATEGIES, LLC","description":"Public Affairs Consulting","address_1":"PO Box 833","address_2":null,"address_3":null,"address_4":null,"city":"Annandale","state":"VA","state_display":"Virginia","zip":"22003","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NATHAN PARSONS-SCHWARZ","contact_telephone":"+1 202-674-7999","dt_updated":"2026-06-30T14:27:52.686768-04:00"},"client":{"id":57350,"url":"https://lda.gov/api/v1/clients/57350/","client_id":57350,"name":"AMERICAN SECURITY FUND","general_description":"Nonprofit advocating for artificial intelligence safety and biosecurity","client_government_entity":null,"client_self_select":false,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-09-12"},"lobbying_activities":[{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Issues related to the funding and development of security surrounding advanced research in artificial intelligence; Specific bill(s) include: S.1409, Kids Online Safety Act; S. 3312, Artificial Intelligence Research, Innovation, and Accountability Act of 2023; S. 3205, Federal Artificial Intelligence Risk Management Act of 2023; H.R. 6149, Protecting Kids on Social Media Act; S. 3050, Artificial Intelligence Advancement Act of 2023; S. 2770, Protect Elections from Deceptive AI Act; S. 2502, Artificial Intelligence Bug Bounty Act of 2023; S. 2399/ H.R. 4704, Artificial Intelligence and Biosecurity Risk Assessment Act; S. 2103/H.R. 3932, Intelligence Authorization Act for Fiscal Year; H.R. 1718, AI for National Security Act; S. 687, Safe Social Media Act; S.3897; H.R. 7567, Protect Victims of Digital Exploitation and Manipulation Act; H.R. 7532, Federal AI Governance and Transparency Act; S.3696, DEFIANCE Act of 2024; H.R. 6943, No AI FRAUD Act; H.R. 8315, Enhancing National Frameworks for Overseas Restriction of Critical Exports Act; S.2714, CREATE AI Act of 2023; S.3162, TEST AI Act of 2023; Senate Amendment 3139 amending bill S.2296, National Defense Authorization Act of 2026; S.1705 Chips Security Act; H.R. 3447 Chips Security Act; H.R. 3919 Advanced AI Security Readiness Act; S.2177 No Adversarial AI Act.; H.R.1736 Generative AI Terrorism Risk Assessment Act; H.R. 8170 MATCH Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":61736,"prefix":null,"prefix_display":null,"first_name":"TYLER","nickname":null,"middle_name":null,"last_name":"DEATON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e4b947a6-4238-4653-8281-d9615ea1d6b8/","filing_uuid":"e4b947a6-4238-4653-8281-d9615ea1d6b8","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/e4b947a6-4238-4653-8281-d9615ea1d6b8/print/","filing_document_content_type":"text/html","income":null,"expenses":"110000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"John Billington","dt_posted":"2026-04-18T21:49:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 Campus Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Florham Park","registrant_state":"NJ","registrant_zip":"07932","registrant":{"id":401107081,"url":"https://lda.gov/api/v1/registrants/401107081/","house_registrant_id":55822,"name":"SHIONOGI INC.","description":null,"address_1":"400 Campus Drive","address_2":null,"address_3":null,"address_4":null,"city":"Florham Park","state":"NJ","state_display":"New Jersey","zip":"07932","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAHLET MAKONNEN","contact_telephone":"+1 202-973-5964","dt_updated":"2026-08-28T12:32:14.815137-04:00"},"client":{"id":53361,"url":"https://lda.gov/api/v1/clients/53361/","client_id":53361,"name":"SHIONOGI INC.","general_description":"Pharmaceutical company","client_government_entity":null,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-10-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e4b947a6-4238-4653-8281-d9615ea1d6b8/","filing_uuid":"e4b947a6-4238-4653-8281-d9615ea1d6b8","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/e4b947a6-4238-4653-8281-d9615ea1d6b8/print/","filing_document_content_type":"text/html","income":null,"expenses":"110000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"John Billington","dt_posted":"2026-04-18T21:49:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 Campus Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Florham Park","registrant_state":"NJ","registrant_zip":"07932","registrant":{"id":401107081,"url":"https://lda.gov/api/v1/registrants/401107081/","house_registrant_id":55822,"name":"SHIONOGI INC.","description":null,"address_1":"400 Campus Drive","address_2":null,"address_3":null,"address_4":null,"city":"Florham Park","state":"NJ","state_display":"New Jersey","zip":"07932","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAHLET MAKONNEN","contact_telephone":"+1 202-973-5964","dt_updated":"2026-08-28T12:32:14.815137-04:00"},"client":{"id":53361,"url":"https://lda.gov/api/v1/clients/53361/","client_id":53361,"name":"SHIONOGI INC.","general_description":"Pharmaceutical company","client_government_entity":null,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-10-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e4b947a6-4238-4653-8281-d9615ea1d6b8/","filing_uuid":"e4b947a6-4238-4653-8281-d9615ea1d6b8","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/e4b947a6-4238-4653-8281-d9615ea1d6b8/print/","filing_document_content_type":"text/html","income":null,"expenses":"110000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"John Billington","dt_posted":"2026-04-18T21:49:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 Campus Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Florham Park","registrant_state":"NJ","registrant_zip":"07932","registrant":{"id":401107081,"url":"https://lda.gov/api/v1/registrants/401107081/","house_registrant_id":55822,"name":"SHIONOGI INC.","description":null,"address_1":"400 Campus Drive","address_2":null,"address_3":null,"address_4":null,"city":"Florham Park","state":"NJ","state_display":"New Jersey","zip":"07932","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAHLET MAKONNEN","contact_telephone":"+1 202-973-5964","dt_updated":"2026-08-28T12:32:14.815137-04:00"},"client":{"id":53361,"url":"https://lda.gov/api/v1/clients/53361/","client_id":53361,"name":"SHIONOGI INC.","general_description":"Pharmaceutical company","client_government_entity":null,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-10-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e4b947a6-4238-4653-8281-d9615ea1d6b8/","filing_uuid":"e4b947a6-4238-4653-8281-d9615ea1d6b8","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/e4b947a6-4238-4653-8281-d9615ea1d6b8/print/","filing_document_content_type":"text/html","income":null,"expenses":"110000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"John Billington","dt_posted":"2026-04-18T21:49:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 Campus Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Florham Park","registrant_state":"NJ","registrant_zip":"07932","registrant":{"id":401107081,"url":"https://lda.gov/api/v1/registrants/401107081/","house_registrant_id":55822,"name":"SHIONOGI INC.","description":null,"address_1":"400 Campus Drive","address_2":null,"address_3":null,"address_4":null,"city":"Florham Park","state":"NJ","state_display":"New Jersey","zip":"07932","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAHLET MAKONNEN","contact_telephone":"+1 202-973-5964","dt_updated":"2026-08-28T12:32:14.815137-04:00"},"client":{"id":53361,"url":"https://lda.gov/api/v1/clients/53361/","client_id":53361,"name":"SHIONOGI INC.","general_description":"Pharmaceutical company","client_government_entity":null,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-10-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e4b947a6-4238-4653-8281-d9615ea1d6b8/","filing_uuid":"e4b947a6-4238-4653-8281-d9615ea1d6b8","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/e4b947a6-4238-4653-8281-d9615ea1d6b8/print/","filing_document_content_type":"text/html","income":null,"expenses":"110000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"John Billington","dt_posted":"2026-04-18T21:49:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 Campus Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Florham Park","registrant_state":"NJ","registrant_zip":"07932","registrant":{"id":401107081,"url":"https://lda.gov/api/v1/registrants/401107081/","house_registrant_id":55822,"name":"SHIONOGI INC.","description":null,"address_1":"400 Campus Drive","address_2":null,"address_3":null,"address_4":null,"city":"Florham Park","state":"NJ","state_display":"New Jersey","zip":"07932","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAHLET MAKONNEN","contact_telephone":"+1 202-973-5964","dt_updated":"2026-08-28T12:32:14.815137-04:00"},"client":{"id":53361,"url":"https://lda.gov/api/v1/clients/53361/","client_id":53361,"name":"SHIONOGI INC.","general_description":"Pharmaceutical company","client_government_entity":null,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-10-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e4b947a6-4238-4653-8281-d9615ea1d6b8/","filing_uuid":"e4b947a6-4238-4653-8281-d9615ea1d6b8","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/e4b947a6-4238-4653-8281-d9615ea1d6b8/print/","filing_document_content_type":"text/html","income":null,"expenses":"110000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"John Billington","dt_posted":"2026-04-18T21:49:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 Campus Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Florham Park","registrant_state":"NJ","registrant_zip":"07932","registrant":{"id":401107081,"url":"https://lda.gov/api/v1/registrants/401107081/","house_registrant_id":55822,"name":"SHIONOGI INC.","description":null,"address_1":"400 Campus Drive","address_2":null,"address_3":null,"address_4":null,"city":"Florham Park","state":"NJ","state_display":"New Jersey","zip":"07932","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAHLET MAKONNEN","contact_telephone":"+1 202-973-5964","dt_updated":"2026-08-28T12:32:14.815137-04:00"},"client":{"id":53361,"url":"https://lda.gov/api/v1/clients/53361/","client_id":53361,"name":"SHIONOGI INC.","general_description":"Pharmaceutical company","client_government_entity":null,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-10-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e4b947a6-4238-4653-8281-d9615ea1d6b8/","filing_uuid":"e4b947a6-4238-4653-8281-d9615ea1d6b8","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/e4b947a6-4238-4653-8281-d9615ea1d6b8/print/","filing_document_content_type":"text/html","income":null,"expenses":"110000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"John Billington","dt_posted":"2026-04-18T21:49:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 Campus Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Florham Park","registrant_state":"NJ","registrant_zip":"07932","registrant":{"id":401107081,"url":"https://lda.gov/api/v1/registrants/401107081/","house_registrant_id":55822,"name":"SHIONOGI INC.","description":null,"address_1":"400 Campus Drive","address_2":null,"address_3":null,"address_4":null,"city":"Florham Park","state":"NJ","state_display":"New Jersey","zip":"07932","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAHLET MAKONNEN","contact_telephone":"+1 202-973-5964","dt_updated":"2026-08-28T12:32:14.815137-04:00"},"client":{"id":53361,"url":"https://lda.gov/api/v1/clients/53361/","client_id":53361,"name":"SHIONOGI INC.","general_description":"Pharmaceutical company","client_government_entity":null,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-10-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/80af8a52-babd-42c7-a339-03d7f833ecd0/","filing_uuid":"80af8a52-babd-42c7-a339-03d7f833ecd0","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/80af8a52-babd-42c7-a339-03d7f833ecd0/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Gracey Roskam","dt_posted":"2026-04-20T14:00:13-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2923 E Lee Ave","registrant_address_2":"# 6239","registrant_different_address":false,"registrant_city":"Alexandria","registrant_state":"VA","registrant_zip":"22306","registrant":{"id":401107669,"url":"https://lda.gov/api/v1/registrants/401107669/","house_registrant_id":56102,"name":"UPTOWN STRATEGIES INC. (FKA UPTOWN SOLUTIONS LLC)","description":null,"address_1":"2923 E Lee Ave","address_2":"# 6239","address_3":null,"address_4":null,"city":"Alexandria","state":"VA","state_display":"Virginia","zip":"22306","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GRACEY ROSKAM","contact_telephone":"+1 202-753-9764","dt_updated":"2026-07-18T22:05:38.068362-04:00"},"client":{"id":68545,"url":"https://lda.gov/api/v1/clients/68545/","client_id":68545,"name":"AMERICAN SECURITY FUND","general_description":"Nonprofit advocating for artificial intelligence safety and biosecurity","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-08-01"},"lobbying_activities":[{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Issues related to the funding and development of security surrounding advanced research in artificial intelligence; Specific bill(s) include: S.1409, Kids Online Safety Act; S. 3312, Artificial Intelligence Research, Innovation, and Accountability Act of 2023; S. 3205, Federal Artificial Intelligence Risk Management Act of 2023; H.R. 6149, Protecting Kids on Social Media Act; S. 3050, Artificial Intelligence Advancement Act of 2023; S. 2770, Protect Elections from Deceptive AI Act; S. 2502, Artificial Intelligence Bug Bounty Act of 2023; S. 2399/ H.R. 4704, Artificial Intelligence and Biosecurity Risk Assessment Act; S. 2103/H.R. 3932, Intelligence Authorization Act for Fiscal Year; H.R. 1718, AI for National Security Act; S. 687, Safe Social Media Act; S.3897, Preparing Election Administrators for AI Act; H.R. 7567, Protect Victims of Digital Exploitation and Manipulation Act; H.R. 7532, Federal AI Governance and Transparency Act; S.3696, DEFIANCE Act of 2024; H.R. 6943, No AI FRAUD Act; H.R. 8315, Enhancing National Frameworks for Overseas Restriction of Critical Exports Act; S.2714, CREATE AI Act of 2023; S.3162, TEST AI Act of 2023; Senate Amendment 3139 amending bill S.4638, National Defense Authorization Act of 2024.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142923,"prefix":null,"prefix_display":null,"first_name":"GRACEY","nickname":null,"middle_name":null,"last_name":"ROSKAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/9e120cd1-3f3f-49b7-90e4-54710ce912f9/","filing_uuid":"9e120cd1-3f3f-49b7-90e4-54710ce912f9","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/9e120cd1-3f3f-49b7-90e4-54710ce912f9/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Gracey Roskam","dt_posted":"2026-07-11T13:49:59-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2923 E Lee Ave","registrant_address_2":"# 6239","registrant_different_address":false,"registrant_city":"Alexandria","registrant_state":"VA","registrant_zip":"22306","registrant":{"id":401107669,"url":"https://lda.gov/api/v1/registrants/401107669/","house_registrant_id":56102,"name":"UPTOWN STRATEGIES INC. (FKA UPTOWN SOLUTIONS LLC)","description":null,"address_1":"2923 E Lee Ave","address_2":"# 6239","address_3":null,"address_4":null,"city":"Alexandria","state":"VA","state_display":"Virginia","zip":"22306","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GRACEY ROSKAM","contact_telephone":"+1 202-753-9764","dt_updated":"2026-07-18T22:05:38.068362-04:00"},"client":{"id":68545,"url":"https://lda.gov/api/v1/clients/68545/","client_id":68545,"name":"AMERICAN SECURITY FUND","general_description":"Nonprofit advocating for artificial intelligence safety and biosecurity","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-08-01"},"lobbying_activities":[{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Issues related to the funding and development of security surrounding advanced research in artificial intelligence; Specific bill(s) include: S.1409, Kids Online Safety Act; S. 3312, Artificial Intelligence Research, Innovation, and Accountability Act of 2023; S. 3205, Federal Artificial Intelligence Risk Management Act of 2023; H.R. 6149, Protecting Kids on Social Media Act; S. 3050, Artificial Intelligence Advancement Act of 2023; S. 2770, Protect Elections from Deceptive AI Act; S. 2502, Artificial Intelligence Bug Bounty Act of 2023; S. 2399/ H.R. 4704, Artificial Intelligence and Biosecurity Risk Assessment Act; S. 2103/H.R. 3932, Intelligence Authorization Act for Fiscal Year; H.R. 1718, AI for National Security Act; S. 687, Safe Social Media Act; S.3897, Preparing Election Administrators for AI Act; H.R. 7567, Protect Victims of Digital Exploitation and Manipulation Act; H.R. 7532, Federal AI Governance and Transparency Act; S.3696, DEFIANCE Act of 2024; H.R. 6943, No AI FRAUD Act; H.R. 8315, Enhancing National Frameworks for Overseas Restriction of Critical Exports Act; S.2714, CREATE AI Act of 2023; S.3162, TEST AI Act of 2023; Senate Amendment 3139 amending bill S.4638, National Defense Authorization Act of 2024.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142923,"prefix":null,"prefix_display":null,"first_name":"GRACEY","nickname":null,"middle_name":null,"last_name":"ROSKAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/f0f851b0-7e4e-4e1a-9405-fa81b95b037c/","filing_uuid":"f0f851b0-7e4e-4e1a-9405-fa81b95b037c","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/f0f851b0-7e4e-4e1a-9405-fa81b95b037c/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Nathan Parsons-Schwarz","dt_posted":"2026-07-20T17:21:04-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"PO Box 833","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Annandale","registrant_state":"VA","registrant_zip":"22003","registrant":{"id":400531585,"url":"https://lda.gov/api/v1/registrants/400531585/","house_registrant_id":null,"name":"ALLEGIANCE STRATEGIES, LLC","description":"Public Affairs Consulting","address_1":"PO Box 833","address_2":null,"address_3":null,"address_4":null,"city":"Annandale","state":"VA","state_display":"Virginia","zip":"22003","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NATHAN PARSONS-SCHWARZ","contact_telephone":"+1 202-674-7999","dt_updated":"2026-06-30T14:27:52.686768-04:00"},"client":{"id":57350,"url":"https://lda.gov/api/v1/clients/57350/","client_id":57350,"name":"AMERICAN SECURITY FUND","general_description":"Nonprofit advocating for artificial intelligence safety and biosecurity","client_government_entity":null,"client_self_select":false,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-09-12"},"lobbying_activities":[{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Issues related to the funding and development of security surrounding advanced research in artificial intelligence; Specific bill(s) include: S.1409, Kids Online Safety Act; S. 3312, Artificial Intelligence Research, Innovation, and Accountability Act of 2023; S. 3205, Federal Artificial Intelligence Risk Management Act of 2023; H.R. 6149, Protecting Kids on Social Media Act; S. 3050, Artificial Intelligence Advancement Act of 2023; S. 2770, Protect Elections from Deceptive AI Act; S. 2502, Artificial Intelligence Bug Bounty Act of 2023; S. 2399/ H.R. 4704, Artificial Intelligence and Biosecurity Risk Assessment Act; S. 2103/H.R. 3932, Intelligence Authorization Act for Fiscal Year; H.R. 1718, AI for National Security Act; S. 687, Safe Social Media Act; S.3897; H.R. 7567, Protect Victims of Digital Exploitation and Manipulation Act; H.R. 7532, Federal AI Governance and Transparency Act; S.3696, DEFIANCE Act of 2024; H.R. 6943, No AI FRAUD Act; H.R. 8315, Enhancing National Frameworks for Overseas Restriction of Critical Exports Act; S.2714, CREATE AI Act of 2023; S.3162, TEST AI Act of 2023; Senate Amendment 3139 amending bill S.2296, National Defense Authorization Act of 2026; S.1705 Chips Security Act; H.R. 3447 Chips Security Act; H.R. 3919 Advanced AI Security Readiness Act; S.2177 No Adversarial AI Act.; H.R.1736 Generative AI Terrorism Risk Assessment Act; H.R. 8170 MATCH Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":61736,"prefix":null,"prefix_display":null,"first_name":"TYLER","nickname":null,"middle_name":null,"last_name":"DEATON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/ecab1159-4610-425d-b9f7-e02c143d145d/","filing_uuid":"ecab1159-4610-425d-b9f7-e02c143d145d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/ecab1159-4610-425d-b9f7-e02c143d145d/print/","filing_document_content_type":"text/html","income":null,"expenses":"50000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"John Billington","dt_posted":"2026-07-20T19:36:28-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 Campus Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Florham Park","registrant_state":"NJ","registrant_zip":"07932","registrant":{"id":401107081,"url":"https://lda.gov/api/v1/registrants/401107081/","house_registrant_id":55822,"name":"SHIONOGI INC.","description":null,"address_1":"400 Campus Drive","address_2":null,"address_3":null,"address_4":null,"city":"Florham Park","state":"NJ","state_display":"New Jersey","zip":"07932","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAHLET MAKONNEN","contact_telephone":"+1 202-973-5964","dt_updated":"2026-08-28T12:32:14.815137-04:00"},"client":{"id":53361,"url":"https://lda.gov/api/v1/clients/53361/","client_id":53361,"name":"SHIONOGI INC.","general_description":"Pharmaceutical company","client_government_entity":null,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-10-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/ecab1159-4610-425d-b9f7-e02c143d145d/","filing_uuid":"ecab1159-4610-425d-b9f7-e02c143d145d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/ecab1159-4610-425d-b9f7-e02c143d145d/print/","filing_document_content_type":"text/html","income":null,"expenses":"50000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"John Billington","dt_posted":"2026-07-20T19:36:28-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 Campus Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Florham Park","registrant_state":"NJ","registrant_zip":"07932","registrant":{"id":401107081,"url":"https://lda.gov/api/v1/registrants/401107081/","house_registrant_id":55822,"name":"SHIONOGI INC.","description":null,"address_1":"400 Campus Drive","address_2":null,"address_3":null,"address_4":null,"city":"Florham Park","state":"NJ","state_display":"New Jersey","zip":"07932","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAHLET MAKONNEN","contact_telephone":"+1 202-973-5964","dt_updated":"2026-08-28T12:32:14.815137-04:00"},"client":{"id":53361,"url":"https://lda.gov/api/v1/clients/53361/","client_id":53361,"name":"SHIONOGI INC.","general_description":"Pharmaceutical company","client_government_entity":null,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-10-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/ecab1159-4610-425d-b9f7-e02c143d145d/","filing_uuid":"ecab1159-4610-425d-b9f7-e02c143d145d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/ecab1159-4610-425d-b9f7-e02c143d145d/print/","filing_document_content_type":"text/html","income":null,"expenses":"50000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"John Billington","dt_posted":"2026-07-20T19:36:28-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 Campus Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Florham Park","registrant_state":"NJ","registrant_zip":"07932","registrant":{"id":401107081,"url":"https://lda.gov/api/v1/registrants/401107081/","house_registrant_id":55822,"name":"SHIONOGI INC.","description":null,"address_1":"400 Campus Drive","address_2":null,"address_3":null,"address_4":null,"city":"Florham Park","state":"NJ","state_display":"New Jersey","zip":"07932","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAHLET MAKONNEN","contact_telephone":"+1 202-973-5964","dt_updated":"2026-08-28T12:32:14.815137-04:00"},"client":{"id":53361,"url":"https://lda.gov/api/v1/clients/53361/","client_id":53361,"name":"SHIONOGI INC.","general_description":"Pharmaceutical company","client_government_entity":null,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-10-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/ecab1159-4610-425d-b9f7-e02c143d145d/","filing_uuid":"ecab1159-4610-425d-b9f7-e02c143d145d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/ecab1159-4610-425d-b9f7-e02c143d145d/print/","filing_document_content_type":"text/html","income":null,"expenses":"50000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"John Billington","dt_posted":"2026-07-20T19:36:28-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 Campus Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Florham Park","registrant_state":"NJ","registrant_zip":"07932","registrant":{"id":401107081,"url":"https://lda.gov/api/v1/registrants/401107081/","house_registrant_id":55822,"name":"SHIONOGI INC.","description":null,"address_1":"400 Campus Drive","address_2":null,"address_3":null,"address_4":null,"city":"Florham Park","state":"NJ","state_display":"New Jersey","zip":"07932","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAHLET MAKONNEN","contact_telephone":"+1 202-973-5964","dt_updated":"2026-08-28T12:32:14.815137-04:00"},"client":{"id":53361,"url":"https://lda.gov/api/v1/clients/53361/","client_id":53361,"name":"SHIONOGI INC.","general_description":"Pharmaceutical company","client_government_entity":null,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-10-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/ecab1159-4610-425d-b9f7-e02c143d145d/","filing_uuid":"ecab1159-4610-425d-b9f7-e02c143d145d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/ecab1159-4610-425d-b9f7-e02c143d145d/print/","filing_document_content_type":"text/html","income":null,"expenses":"50000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"John Billington","dt_posted":"2026-07-20T19:36:28-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 Campus Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Florham Park","registrant_state":"NJ","registrant_zip":"07932","registrant":{"id":401107081,"url":"https://lda.gov/api/v1/registrants/401107081/","house_registrant_id":55822,"name":"SHIONOGI INC.","description":null,"address_1":"400 Campus Drive","address_2":null,"address_3":null,"address_4":null,"city":"Florham Park","state":"NJ","state_display":"New Jersey","zip":"07932","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAHLET MAKONNEN","contact_telephone":"+1 202-973-5964","dt_updated":"2026-08-28T12:32:14.815137-04:00"},"client":{"id":53361,"url":"https://lda.gov/api/v1/clients/53361/","client_id":53361,"name":"SHIONOGI INC.","general_description":"Pharmaceutical company","client_government_entity":null,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-10-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/ecab1159-4610-425d-b9f7-e02c143d145d/","filing_uuid":"ecab1159-4610-425d-b9f7-e02c143d145d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/ecab1159-4610-425d-b9f7-e02c143d145d/print/","filing_document_content_type":"text/html","income":null,"expenses":"50000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"John Billington","dt_posted":"2026-07-20T19:36:28-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 Campus Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Florham Park","registrant_state":"NJ","registrant_zip":"07932","registrant":{"id":401107081,"url":"https://lda.gov/api/v1/registrants/401107081/","house_registrant_id":55822,"name":"SHIONOGI INC.","description":null,"address_1":"400 Campus Drive","address_2":null,"address_3":null,"address_4":null,"city":"Florham Park","state":"NJ","state_display":"New Jersey","zip":"07932","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAHLET MAKONNEN","contact_telephone":"+1 202-973-5964","dt_updated":"2026-08-28T12:32:14.815137-04:00"},"client":{"id":53361,"url":"https://lda.gov/api/v1/clients/53361/","client_id":53361,"name":"SHIONOGI INC.","general_description":"Pharmaceutical company","client_government_entity":null,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-10-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/ecab1159-4610-425d-b9f7-e02c143d145d/","filing_uuid":"ecab1159-4610-425d-b9f7-e02c143d145d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/ecab1159-4610-425d-b9f7-e02c143d145d/print/","filing_document_content_type":"text/html","income":null,"expenses":"50000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"John Billington","dt_posted":"2026-07-20T19:36:28-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 Campus Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Florham Park","registrant_state":"NJ","registrant_zip":"07932","registrant":{"id":401107081,"url":"https://lda.gov/api/v1/registrants/401107081/","house_registrant_id":55822,"name":"SHIONOGI INC.","description":null,"address_1":"400 Campus Drive","address_2":null,"address_3":null,"address_4":null,"city":"Florham Park","state":"NJ","state_display":"New Jersey","zip":"07932","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAHLET MAKONNEN","contact_telephone":"+1 202-973-5964","dt_updated":"2026-08-28T12:32:14.815137-04:00"},"client":{"id":53361,"url":"https://lda.gov/api/v1/clients/53361/","client_id":53361,"name":"SHIONOGI INC.","general_description":"Pharmaceutical company","client_government_entity":null,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-10-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/be936ef6-0961-440a-ae91-dba20687b67f/","filing_uuid":"be936ef6-0961-440a-ae91-dba20687b67f","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/be936ef6-0961-440a-ae91-dba20687b67f/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Gracey Roskam","dt_posted":"2026-10-16T12:48:28-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2923 E Lee Ave","registrant_address_2":"# 6239","registrant_different_address":false,"registrant_city":"Alexandria","registrant_state":"VA","registrant_zip":"22306","registrant":{"id":401107669,"url":"https://lda.gov/api/v1/registrants/401107669/","house_registrant_id":56102,"name":"UPTOWN STRATEGIES INC. (FKA UPTOWN SOLUTIONS LLC)","description":null,"address_1":"2923 E Lee Ave","address_2":"# 6239","address_3":null,"address_4":null,"city":"Alexandria","state":"VA","state_display":"Virginia","zip":"22306","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GRACEY ROSKAM","contact_telephone":"+1 202-753-9764","dt_updated":"2026-07-18T22:05:38.068362-04:00"},"client":{"id":68545,"url":"https://lda.gov/api/v1/clients/68545/","client_id":68545,"name":"AMERICAN SECURITY FUND","general_description":"Nonprofit advocating for artificial intelligence safety and biosecurity","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-08-01"},"lobbying_activities":[{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Issues related to the funding and development of security surrounding advanced research in artificial intelligence; Specific bill(s) include: S.1409, Kids Online Safety Act; S. 3312, Artificial Intelligence Research, Innovation, and Accountability Act of 2023; S. 3205, Federal Artificial Intelligence Risk Management Act of 2023; H.R. 6149, Protecting Kids on Social Media Act; S. 3050, Artificial Intelligence Advancement Act of 2023; S. 2770, Protect Elections from Deceptive AI Act; S. 2502, Artificial Intelligence Bug Bounty Act of 2023; S. 2399/ H.R. 4704, Artificial Intelligence and Biosecurity Risk Assessment Act; S. 2103/H.R. 3932, Intelligence Authorization Act for Fiscal Year; H.R. 1718, AI for National Security Act; S. 687, Safe Social Media Act; S.3897, Preparing Election Administrators for AI Act; H.R. 7567, Protect Victims of Digital Exploitation and Manipulation Act; H.R. 7532, Federal AI Governance and Transparency Act; S.3696, DEFIANCE Act of 2024; H.R. 6943, No AI FRAUD Act; H.R. 8315, Enhancing National Frameworks for Overseas Restriction of Critical Exports Act; S.2714, CREATE AI Act of 2023; S.3162, TEST AI Act of 2023; Senate Amendment 3139 amending bill S.4638, National Defense Authorization Act of 2024.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142923,"prefix":null,"prefix_display":null,"first_name":"GRACEY","nickname":null,"middle_name":null,"last_name":"ROSKAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/d42bfa1d-ab49-40e1-9137-30dfde6f9118/","filing_uuid":"d42bfa1d-ab49-40e1-9137-30dfde6f9118","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/d42bfa1d-ab49-40e1-9137-30dfde6f9118/print/","filing_document_content_type":"text/html","income":null,"expenses":"50000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"John Billington","dt_posted":"2026-10-19T17:36:21-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 Campus Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Florham Park","registrant_state":"NJ","registrant_zip":"07932","registrant":{"id":401107081,"url":"https://lda.gov/api/v1/registrants/401107081/","house_registrant_id":55822,"name":"SHIONOGI INC.","description":null,"address_1":"400 Campus Drive","address_2":null,"address_3":null,"address_4":null,"city":"Florham Park","state":"NJ","state_display":"New Jersey","zip":"07932","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAHLET MAKONNEN","contact_telephone":"+1 202-973-5964","dt_updated":"2026-08-28T12:32:14.815137-04:00"},"client":{"id":53361,"url":"https://lda.gov/api/v1/clients/53361/","client_id":53361,"name":"SHIONOGI INC.","general_description":"Pharmaceutical company","client_government_entity":null,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-10-01"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/d42bfa1d-ab49-40e1-9137-30dfde6f9118/","filing_uuid":"d42bfa1d-ab49-40e1-9137-30dfde6f9118","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/d42bfa1d-ab49-40e1-9137-30dfde6f9118/print/","filing_document_content_type":"text/html","income":null,"expenses":"50000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"John Billington","dt_posted":"2026-10-19T17:36:21-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 Campus Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Florham Park","registrant_state":"NJ","registrant_zip":"07932","registrant":{"id":401107081,"url":"https://lda.gov/api/v1/registrants/401107081/","house_registrant_id":55822,"name":"SHIONOGI INC.","description":null,"address_1":"400 Campus Drive","address_2":null,"address_3":null,"address_4":null,"city":"Florham Park","state":"NJ","state_display":"New Jersey","zip":"07932","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAHLET MAKONNEN","contact_telephone":"+1 202-973-5964","dt_updated":"2026-08-28T12:32:14.815137-04:00"},"client":{"id":53361,"url":"https://lda.gov/api/v1/clients/53361/","client_id":53361,"name":"SHIONOGI INC.","general_description":"Pharmaceutical company","client_government_entity":null,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-10-01"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/d42bfa1d-ab49-40e1-9137-30dfde6f9118/","filing_uuid":"d42bfa1d-ab49-40e1-9137-30dfde6f9118","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/d42bfa1d-ab49-40e1-9137-30dfde6f9118/print/","filing_document_content_type":"text/html","income":null,"expenses":"50000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"John Billington","dt_posted":"2026-10-19T17:36:21-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 Campus Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Florham Park","registrant_state":"NJ","registrant_zip":"07932","registrant":{"id":401107081,"url":"https://lda.gov/api/v1/registrants/401107081/","house_registrant_id":55822,"name":"SHIONOGI INC.","description":null,"address_1":"400 Campus Drive","address_2":null,"address_3":null,"address_4":null,"city":"Florham Park","state":"NJ","state_display":"New Jersey","zip":"07932","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAHLET MAKONNEN","contact_telephone":"+1 202-973-5964","dt_updated":"2026-08-28T12:32:14.815137-04:00"},"client":{"id":53361,"url":"https://lda.gov/api/v1/clients/53361/","client_id":53361,"name":"SHIONOGI INC.","general_description":"Pharmaceutical company","client_government_entity":null,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-10-01"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/d42bfa1d-ab49-40e1-9137-30dfde6f9118/","filing_uuid":"d42bfa1d-ab49-40e1-9137-30dfde6f9118","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/d42bfa1d-ab49-40e1-9137-30dfde6f9118/print/","filing_document_content_type":"text/html","income":null,"expenses":"50000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"John Billington","dt_posted":"2026-10-19T17:36:21-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 Campus Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Florham Park","registrant_state":"NJ","registrant_zip":"07932","registrant":{"id":401107081,"url":"https://lda.gov/api/v1/registrants/401107081/","house_registrant_id":55822,"name":"SHIONOGI INC.","description":null,"address_1":"400 Campus Drive","address_2":null,"address_3":null,"address_4":null,"city":"Florham Park","state":"NJ","state_display":"New Jersey","zip":"07932","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAHLET MAKONNEN","contact_telephone":"+1 202-973-5964","dt_updated":"2026-08-28T12:32:14.815137-04:00"},"client":{"id":53361,"url":"https://lda.gov/api/v1/clients/53361/","client_id":53361,"name":"SHIONOGI INC.","general_description":"Pharmaceutical company","client_government_entity":null,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-10-01"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/d42bfa1d-ab49-40e1-9137-30dfde6f9118/","filing_uuid":"d42bfa1d-ab49-40e1-9137-30dfde6f9118","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/d42bfa1d-ab49-40e1-9137-30dfde6f9118/print/","filing_document_content_type":"text/html","income":null,"expenses":"50000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"John Billington","dt_posted":"2026-10-19T17:36:21-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 Campus Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Florham Park","registrant_state":"NJ","registrant_zip":"07932","registrant":{"id":401107081,"url":"https://lda.gov/api/v1/registrants/401107081/","house_registrant_id":55822,"name":"SHIONOGI INC.","description":null,"address_1":"400 Campus Drive","address_2":null,"address_3":null,"address_4":null,"city":"Florham Park","state":"NJ","state_display":"New Jersey","zip":"07932","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAHLET MAKONNEN","contact_telephone":"+1 202-973-5964","dt_updated":"2026-08-28T12:32:14.815137-04:00"},"client":{"id":53361,"url":"https://lda.gov/api/v1/clients/53361/","client_id":53361,"name":"SHIONOGI INC.","general_description":"Pharmaceutical company","client_government_entity":null,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-10-01"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/d42bfa1d-ab49-40e1-9137-30dfde6f9118/","filing_uuid":"d42bfa1d-ab49-40e1-9137-30dfde6f9118","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/d42bfa1d-ab49-40e1-9137-30dfde6f9118/print/","filing_document_content_type":"text/html","income":null,"expenses":"50000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"John Billington","dt_posted":"2026-10-19T17:36:21-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 Campus Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Florham Park","registrant_state":"NJ","registrant_zip":"07932","registrant":{"id":401107081,"url":"https://lda.gov/api/v1/registrants/401107081/","house_registrant_id":55822,"name":"SHIONOGI INC.","description":null,"address_1":"400 Campus Drive","address_2":null,"address_3":null,"address_4":null,"city":"Florham Park","state":"NJ","state_display":"New Jersey","zip":"07932","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAHLET MAKONNEN","contact_telephone":"+1 202-973-5964","dt_updated":"2026-08-28T12:32:14.815137-04:00"},"client":{"id":53361,"url":"https://lda.gov/api/v1/clients/53361/","client_id":53361,"name":"SHIONOGI INC.","general_description":"Pharmaceutical company","client_government_entity":null,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-10-01"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}